
Core Viewpoint - Milestone Pharmaceuticals Inc. (MIST) is showing potential for bullish momentum following a technical indicator known as a "golden cross" which occurred when its 50-day simple moving average surpassed its 200-day moving average [1][2] Technical Analysis - The golden cross is characterized by three stages: a downtrend that bottoms out, a crossover of the shorter moving average above the longer one, and continued upward momentum [1] - MIST has experienced a price increase of 15.7% over the last four weeks, indicating a possible breakout [2] - The current Zacks Rank for MIST is 3 (Hold), suggesting a neutral outlook [2] Earnings Outlook - There has been a positive shift in earnings estimates for MIST, with no estimates decreasing in the past two months and two revisions higher [2] - The Zacks Consensus Estimate for earnings has also increased, reinforcing the bullish sentiment around MIST [2]